Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Executive Summary

• Seegnal Inc. announced an expanded deployment of its Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, covering the period Jan 1 2026 – Dec 31 2027 with an option to extend to 2031.
• The platform will now support roughly 1,200 clinicians and 2,050 medical‑team members across multiple departments, reinforcing Seegnal’s role as a reference site for large public hospitals worldwide.
• The expansion underscores measurable clinical and economic benefits (reduced medication‑related adverse events, lower hospitalizations, decreased alert fatigue) that Seegnal cites from peer‑reviewed research, positioning the partnership as a showcase for future global roll‑outs.

Key Details

• Deployment Period: Jan 1 2026 – Dec 31 2027 (option to extend to Dec 31 2031).
• Scope of Use: Approximately 1,200 clinicians and 2,050 medical‑team members will use the SaaS platform daily as part of routine workflows.
• Clinical Coverage: Platform integrated across multiple inpatient and outpatient departments, delivering real‑time, patient‑specific medication decision support (lab results, comorbidities, renal function, polypharmacy, etc.).
• Reference Site Role: Sourasky Medical Center serves as an active global reference site for other hospitals evaluating modern medication safety solutions.
• Reported Benefits (per cited American Journal of Pharmacy Benefits article):
• Reductions in medication‑related adverse events.
• Fewer avoidable hospitalizations.
• Decreased unnecessary medication utilization.
• Improved prescribing efficiency and reduced alert fatigue.
• Lower downstream costs and better alignment with value‑based care frameworks.
• CEO Quote: “The expansion of our deployment reflects strong confidence in the clinical, operational, and economic value Seegnal delivers at scale.” – Elad Bibi‑Aviv, CEO.

Notable Quotes

“Sourasky Medical Center represents one of the most advanced clinical environments within public health systems worldwide.” – Elad Bibi‑Aviv, Chief Executive Officer, Seegnal.
“The expansion demonstrates that patient‑specific prescribing intelligence can improve safety and efficiency while supporting sustainable economics for large medical centers.” – Elad Bibi‑Aviv, CEO.